The global antiepileptic drugs market is anticipated to grow at a significant CAGR of 2.6% during the forecast period. Antiepileptic drug is known as antiseizure drugs. It is used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes abnormal brain function and irregular behaviour, and occasional loss of consciousness. The increasing prevalence of epilepsy is contributing to the growth of the market. For instance, according to World Health Organization (WHO), Epilepsy affects an estimated 5 million individuals worldwide each year. Epilepsy is projected to affect 49 out of every 1,00, 000 people in high-income nations each year. This rate can be as high as 139 per 1,00,000 in low- and middle-income nations.
Get Free Sample link @ https://www.omrglobal.com/request-sample/antiepileptic-drugs-market
Antiepileptic drugs, in addition to treating epilepsy and seizures, can also be used to alleviate neuropathic pain. Epileptic seizures have yet to be precisely defined or determined. However, occurrences such as substance abuse disorders, strokes, and brain injuries are the most common causes of epilepsy. Antiepileptic drugs or medicines (AEDs) are provided for the treatment of epilepsy based on the patient’s age, the portion of the brain affected, and the type of seizures to be treated. Furthermore, the growing elderly population, changing dietary habits, increased alcohol consumption, and smoking are all contributing to the worldwide anti-epileptic medications market’s rise. In the market, anti-epileptic pharmaceuticals are also known as anti-seizure drugs.
A full report of Global Antiepileptic Drugs Market available @ https://www.omrglobal.com/industry-reports/antiepileptic-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Antiepileptic Drugs Market by Drug Type
First Generation AEDs
- Phenytoin (Dilantin, Phenytek)
- Carbamazepine (Carbatrol)
- Oxycarbazepine (Trileptal)
- Valproate (Depakote)
- Others (Topiramate, Primidone)
Second Generation AEDs
- Lamotrigine (Lamictal)
- Pregabalin (Lyrica)
- Rufinamide (Banzel/Inovelon)
- Levetiracetam (Keppra)
- Others (Lacosamide. Perampanel)
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Abbott Laboratories
- Cephalon, Inc.
- Eisai Co.
- GlaxoSmithKline plc
- GW Pharmaceuticals Inc.
- Lundbeck A/S
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Sunovion Pharmaceuticals Inc.
- Takeda Pharmaceutical Co. Ltd.
- UCB S.A.
- Valeany Pharmaceuticals International Inc.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global antiepileptic drugs market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antiepileptic-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
